Cryoballoon Pulmonary Vein Isolation for Atrial Fibrillation With Heart Failure

  • STATUS
    Recruiting
  • days left to enroll
    78
  • participants needed
    280
  • sponsor
    St. Josefs-Hospital Wiesbaden GmbH
Updated on 19 February 2024
heart failure
atrial fibrillation
radiofrequency ablation
persistent atrial fibrillation
fibrillation
pulmonary vein isolation

Summary

The combination of atrial fibrillation (AF) and heart failure (HF) is common and implies a poor prognosis. Pulmonary vein isolation is an established method for the treatment of symptomatic AF in patients with normal heart function and has been shown to be more effective than drug therapy. Recently, radiofrequency ablation has shown a positive effect in patients with AF and HF. POLAR-HF has been designed to investigate efficacy and safety of cryoballoon pulmonary vein isolation in patients with paroxysmal or persistent AF and severe HF (LVEF 40%).

Details
Condition Arrhythmia, Arrhythmia, Atrial Fibrillation, Atrial Fibrillation, atrial fibrillation (pediatric), Heart failure, Heart failure, Heart disease, Heart disease, atrial fibrillation (pediatric), Cryoballon Ablation
Age 18-99 years
Treatment Cryoballoon Pulmonary Vein Isolation
Clinical Study IdentifierNCT04461691
SponsorSt. Josefs-Hospital Wiesbaden GmbH
Last Modified on19 February 2024

Eligibility

Yes No Not Sure

Inclusion Criteria

Symptomatic paroxysmal or persistent atrial fibrillation
Patients with severe heart failure (LVEF 40%, assigned to heart failure group)
Patients with normal cardiac function (assigned to control group)
Age > 18 years
Consent capacity

Exclusion Criteria

Age under 18 years
Pregnancy
Lack of consent capacity
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.